Source: http://www.google.com/patents/USRE42524?dq=6,034,652
Timestamp: 2017-12-15 11:09:16
Document Index: 55388665

Matched Legal Cases: ['Application No. 02729092', 'Application No. 02729092', 'Application No. 2', 'Application No. 2', 'art 1', 'art 1', 'Application No. 2002259107', 'Application No. 2002259107', 'Application No. 2', 'Application No. 2', 'Application No. 05722719', 'Application No. 200580009719', 'Application No. 200580009719']

Patent USRE42524 - Colloidal metal compositions and methods - Google Patents
The present invention comprises compositions and methods for delivery systems of agents, including therapeutic compounds, pharmaceutical agents, drugs, detection agents, nucleic acid sequences and biological factors. In general, these vector compositions comprise a colloidal metal, derivatized PEG (polyethylene...http://www.google.com/patents/USRE42524?utm_source=gb-gplus-sharePatent USRE42524 - Colloidal metal compositions and methods
Publication number USRE42524 E1
Application number US 11/923,344
Also published as US7229841, US7387900, US8785202, US20020192814, US20030053983, US20070160572, US20070231408, US20100143298, US20120134956
Publication number 11923344, 923344, US RE42524 E1, US RE42524E1, US-E1-RE42524, USRE42524 E1, USRE42524E1
Patent Citations (130), Non-Patent Citations (138), Referenced by (2), Classifications (35), Legal Events (3)
US RE42524 E1
9. The composition of claim 1, wherein the anti-cancer therapeutic agent is tumor necrosis factor alpha.
Sample λ Max Absorbance λ@ ½ Max
US5921927 Nov 12, 1997 Jul 13, 1999 Axialtome Australia Pty. Ltd. Positioning method and apparatus for X-ray tomography
US6235093 Jun 28, 1999 May 22, 2001 Daiwa Fine Chemicals Co., Ltd. Aqueous solutions for obtaining noble metals by chemical reductive deposition
US6274552 * Nov 10, 1997 Aug 14, 2001 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US6528485 * Jun 5, 2000 Mar 4, 2003 Applied Research Systems Ars Holding N.V. Site-specific preparation of polyethylene glycol-grf conjugates
US6660058 Aug 22, 2000 Dec 9, 2003 Nanopros, Inc. Preparation of silver and silver alloyed nanoparticles in surfactant solutions
US20020192814 Mar 8, 2002 Dec 19, 2002 Lawrence Tamarkin Colloidal metal compositions and methods
US20030180252 Dec 19, 2002 Sep 25, 2003 Lawrence Tamarkin Methods and compositions for enhancing immune response and for the production of in vitro Mabs
AU757857B2 Title not available
EP0269408A3 Nov 24, 1987 Aug 30, 1989 Genentech, Inc. Tgf-beta in the treatment of inflammatory disorders
EP0486526B1 Aug 7, 1990 May 22, 1996 Peptide Technology Ltd Tumour necrosis factor binding ligands
EP0690722B1 Mar 18, 1994 Jun 30, 2004 Cytimmune Sciences, Inc. Composition and method for reducing toxicity of biologically-active factors
EP1044022B1 Nov 10, 1998 Mar 15, 2006 Cytimmune Sciences, Inc. Compositions and methods for targeted delivery of factors
EP1342518A1 Feb 14, 2001 Sep 10, 2003 Japan Science and Technology Corporation Finely particulate functional metal and finely particulate functional semiconductor each with dispersion stability and process for producing the same
WO1994021288A1 Mar 18, 1994 Sep 29, 1994 Cytimmune Sciences, Inc. Composition and method for reducing toxicity of biologically-active factors
WO1995024918A1 Mar 7, 1995 Sep 21, 1995 Genetics Institute, Inc. Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases
WO1999024077A2 * Nov 10, 1998 May 20, 1999 Cytimmune Sciences, Inc. Compositions and methods for targeted delivery of biologically-active factors
WO2001095942A2 Jun 8, 2001 Dec 20, 2001 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates
WO2005072893A1 Jan 28, 2005 Aug 11, 2005 Cytimmune Sciences, Inc. Functionalized colloidal metal compositions and methods
1 Author: Balkwill et al., Title: The Cytokine Network, Publ: Immunology Today, vol./Iss: 10(9), pp. 299-304, Date: Jan. 1, 1989.
2 Author: Brust et al., Title: Novel Gold-Dithiol Nano-Networks with Non-Metalhe Electronic Properties, Publ: Advanced Materials, vol./Iss: 7(9), pp. 795-797, Date: Jan. 1, 1995.
3 Author: Calabrese et al., Title: Chemotherapy of Neoplastic Diseases, Publ: Goodman & Gilman's The Pharmacological Basis of Therapeutics, vol./Iss: 9th Edition, pp. 1260-1261, Date: Jan. 1, 1996.
4 Author: Carter et al., Title: Appendix C, Publ: Chemotherapy of Cancer, vol./Iss: 2nd Ed., pp. 361-367, Date: Jan. 1, 1981.
5 Author: Ciesiolka et al., Title: An 8- to 10-fold Enhancement in Sensitivity for Quanitation of Proteins by Modified Application of Colloidal Gold (Abstract Only-Applicants do not have complete copy), Publ: Analytical Biochemistry, vol./Iss: 168 (2), pp. 280-283, Date: Feb. 1, 1988.
6 Author: Ciesiolka et al., Title: An 8- to 10-fold Enhancement in Sensitivity for Quanitation of Proteins by Modified Application of Colloidal Gold (Abstract Only—Applicants do not have complete copy), Publ: Analytical Biochemistry, vol./Iss: 168 (2), pp. 280-283, Date: Feb. 1, 1988.
7 Author: Cohen, I., Title: Optimization of Dose-Time Factors for a Tumor and Multiple Associated Normal Tissues, Publ: International Journal of Radiation Oncology, vol./Iss: 13, pp. 251-258, Date: Jan. 1, 1987.
8 Author: Coulombe et al., Title: Cytochemical Demonstrations of Increased Phospholipid Content in Cell Membranes in Chlorphentermine-Induced Phospholipidosis, Publ: Journal of Histochemistry and Cytochemistry, vol./Iss: 37(2), pp. 139-147, Date: Jan. 1, 1989.
9 Author: De Roe et al., Title: A Model of Protein-Colloidal Gold Interactions, Publ: The Journal of Histochemistry and Cytochemistry, vol./Iss: 35(11), pp. 1191-1198, Date: Jan. 1, 1987.
10 Author: De Roe et al., Title: A Model of Protein—Colloidal Gold Interactions, Publ: The Journal of Histochemistry and Cytochemistry, vol./Iss: 35(11), pp. 1191-1198, Date: Jan. 1, 1987.
11 Author: Debrabander et al., Title: Probing Microtobule-Dependent Intracellular Motility with Nanometre Particle Video Ultramicroscopy (nanovid ultramicroscopy) (Abstract Only-Applicants do not have complete copy), Publ: Cytobio, vol./Iss: 43, pp. 273-283, Date: Jan. 1, 1985.
12 Author: Debrabander et al., Title: Probing Microtobule-Dependent Intracellular Motility with Nanometre Particle Video Ultramicroscopy (nanovid ultramicroscopy) (Abstract Only—Applicants do not have complete copy), Publ: Cytobio, vol./Iss: 43, pp. 273-283, Date: Jan. 1, 1985.
13 Author: Deng et al., Title: Self-Assembled Monolayers of Alkanethiolates Presenting Tri(propylene sulfoxide) Groups Resist the Adsorption of Protein, Publ: Journal of the American Chemical Society, vol./Iss: 118(19), pp. 5136-5137, Date: May 15, 1996.
14 Author: Dominguez et al., Title: Effect of Heat Treatment on the Antigen-Binding of Anti-Peroxidase Immunoglobulins in Bovine Colstrum, Publ: Journal of Dairy Science, vol./Iss: 80(12), pp. 3182-3187, Date: Dec. 1, 1998.
15 Author: Eck et al., Title: Chapter 5: Gene-Based Therapy, Publ: Goodman & Gilman's The Pharmacological Basis of Therapeutics, vol./Iss:, pp. 77-101, Date: Jan. 1, 1996.
16 Author: Elliott et al., Title: Analysis of Colloidal Gold Probes by Isoelectric Focusing in Agarose Gels (Abstract Only-Applicants do not have complete copy), Publ: Analytical Biochemisty, vol./Iss: 186(1), pp. 53-59, Date: Apr. 1, 1990.
17 Author: Elliott et al., Title: Analysis of Colloidal Gold Probes by Isoelectric Focusing in Agarose Gels (Abstract Only—Applicants do not have complete copy), Publ: Analytical Biochemisty, vol./Iss: 186(1), pp. 53-59, Date: Apr. 1, 1990.
18 Author: EPO Searching Authority, Title: Search Report EPO-Application No. 02729092.3, Publ: EPO Search Report, vol./Iss:, pp. 1-6, Date: Jul. 13, 2009.
19 Author: EPO Searching Authority, Title: Search Report EPO—Application No. 02729092.3, Publ: EPO Search Report, vol./Iss:, pp. 1-6, Date: Jul. 13, 2009.
20 Author: Fraker et al., Title: Passive Immunization Against Tumor Necrosis Factor Partially Abrogates Interleukin 2 Toxicity, Publ: The Journal of Experimental Medicine, vol./Iss: 170, pp. 1015-1020, Date: Jan. 1, 1989.
21 Author: Fujimoto, D.-CA Office Action, Title: Canadian Office Action cited in CA Application No. 2,448,607, Publ: Canadian Office Action, vol./Iss:, pp. 1-2, Date: Oct. 12, 2010.
22 Author: Fujimoto, D.—CA Office Action, Title: Canadian Office Action cited in CA Application No. 2,448,607, Publ: Canadian Office Action, vol./Iss:, pp. 1-2, Date: Oct. 12, 2010.
23 Author: Goldstein et al., Title: Cardiovascular Effects of Platelet-Activating Factor, Publ: Lipids, vol./Iss: 26(212), pp. 1250-1256, Date: Jan. 1, 1991.
24 Author: Grainger et al., Title: Polymeric Monolayers on Solid Substrates by Spontaneous Adsorption from Solution, Publ: American Chemical Society-Abstracts of Papers, vol./Iss: Part 1, Pages: Paragraph 074, Date: Aug. 20, 1995.
25 Author: Grainger et al., Title: Polymeric Monolayers on Solid Substrates by Spontaneous Adsorption from Solution, Publ: American Chemical Society—Abstracts of Papers, vol./Iss: Part 1, Pages: Paragraph 074, Date: Aug. 20, 1995.
26 Author: Gref et al., Title: The Controlled Intravenous Delivery of Drugs using PEG-Coated Sterically Stabilized Nanospheres, Publ: Advanced Drug Delivery Reviews, vol./Iss: 16, pp. 215-233, Date: Jan. 1, 1995.
27 Author: Gura, T., Title: Systems for Identifying New Drug are Often Faulty, Publ: Science, vol./Iss: 278, pp. 1041-1042, Date: Nov. 7, 1997.
28 Author: Hashimoto et al., Title: Action Site of Circulating Interleukin-1 on the Rabbit Brain, Publ: Brain Research, vol./Iss: 540, pp. 217-223, Date: Jan. 1, 1991.
29 Author: Hisamatsu et al., Title: Platelet Activating Factor Induced Respiratory Mucosal Damage, Publ: Lipds, vol./Iss: 26(12), pp. 1287-1291, Date: Jan. 1, 1991.
30 Author: Hopkins et al., Title: Early Events Following the Binding of Epidermal Growth Factor to Surface Receptors on Ovarian Granulosa Cells, Publ: European Journal of Cell Biology, vol./Iss: 24, pp. 259-264, Date: Jan. 1, 1981.
31 Author: IBM TDB et al., Title: Molecular Glue for Highly Controlled Attachment of Macromolecules to Metals, Publ: IBM Technical Bulletin, vol./Iss: 39(09), pp. 1-5, Date: Sep. 1, 1996.
32 Author: Illum et al., Title: Development of Systems for Targeting the Regional Lymph Nodes for Diagnostic Imaging: In Vivo Behavior of Colloidal PEG-Coated Magnetic Nanospheres in the Rat Following Intestinal Administration, Publ: Pharmaceutical Research, vol./Iss: 18(5), pp. 640-645, Date: Jan. 1, 2001.
33 Author: Japanese Patent Office, Title: Japanese Patent Application 2000-520153 Office Action as translated by Foreign Associate, Publ: Japanese Office Action, vol./Iss:, pp. 1-10, Date: Oct. 6, 2009.
34 Author: Japanese Publication, Title: Japanese Laid-Open Publication No. 9-107980 English Abstract only-of Japanese Patent Application 08-231415, Publ:, vol./Iss:, pp. 1-3, Date: Apr. 28, 1997.
35 Author: Japanese Publication, Title: Japanese Laid-Open Publication No. 9-107980 English Abstract only—of Japanese Patent Application 08-231415, Publ:, vol./Iss:, pp. 1-3, Date: Apr. 28, 1997.
36 Author: Kang et al., Title: Ultrastructural and Immunocytochemical Study of the Uptake and Distribution of Bacterial Lipopolysaccharide in Human Monocytes, Publ: Journal of Leukemia Biology, vol./Iss: 48, pp. 316-332, Date: Jan. 1, 1990.
37 Author: Kirchner et al., Title: The Development of Neutralizing Antibodies in a Patient Receiving Subcutaneous Recombinant and Natural Interleukin-2, Publ: Cancer, vol./Iss: 67(7), pp. 1862-1864, Date: Apr. 1, 1991.
38 Author: Klotz et a., Title: Macromolecule-Small Molecule Interactions: Strong Binding by Intramolecularly Cross-Linked Polylysine, Publ: Biochemistry, vol./Iss: 10(6), pp. 923-926, Date: Jan. 1, 1971.
39 Author: Koning, et al., Title: Selective Transfer of a Lipophilic Prodrug of 5-Fluorodeoxyuridine from Immunoliposomes to Colon Cancer Cells, Publ: Biochimica et Biphysica Acta, vol./Iss: 1420, pp. 153-167, Date: Jun. 2, 1999.
40 Author: Krontiris, T.G., Title: Chapter 71: Molecular and Cellular Biology of Cancer, Publ: Internal Medicine, vol./Iss: 4th Ed., pp. 699-729, Date: Jan. 1, 1994.
41 Author: Lang et al., Title: A New Class of Thiolipids for the Attachment of Lipid Bilayers on Gold Surfaces, Publ: Langmuit, vol./Iss: 10(1), pp. 197-210, Date: Jan. 1, 1994.
42 Author: Lanzavecchia, Title: Identifying Strategies for Immune Interveator, Publ: Science, vol./Iss: 260, pp. 937-944, Date: Jan. 1, 1993.
43 Author: Lemmon et al., Title: Preparation and Characterization of Nanocomposites of Poly(ethylene oxide) with Layered Solids, Publ:, vol./Iss:, pp. 43-54, Date: Jan. 1, 1995.
44 Author: Leuvering et al., Title: A Sol Particle Agglutination Assay for Human Chorionic Gonadotrophin (Abstract Only-Applicants do not have complete copy), Publ: Journal of Immunological Methods, vol./Iss: 45(2), pp. 183-194, Date: Jan. 1, 1981.
45 Author: Leuvering et al., Title: A Sol Particle Agglutination Assay for Human Chorionic Gonadotrophin (Abstract Only—Applicants do not have complete copy), Publ: Journal of Immunological Methods, vol./Iss: 45(2), pp. 183-194, Date: Jan. 1, 1981.
46 Author: Lezzi et al., Title: Chelating Resins Supporting Dithiocarbamate and Methylthiourea Groups in Adsorption of Heavy Metal Ions, Publ: Journal of Applied Polymer Science, vol./Iss: 54(7), pp. 889-897, Date: Nov. 14, 1994.
47 Author: Lezzi et al., Title: Synthesis of Thiol Chelating Resins and Their Adsorption Properties toward Heavy Metal Ions, Publ: Journal of Polymer Science, vol./Iss: 32, pp. 1877-1883, Date: Jan. 1, 1994.
48 Author: Li et al., Title: Plasma Protein Interactions with Copolymer-Stabilized Colloids, Publ: Dissertation Abstracts International, vol./Iss: 54(7), pp. 3735-B, Date: Jan. 1, 1994.
49 Author: Magez et al., Title: Specific Uptake Tumor Necrosis Factor-a is Involved in Growth Control of Trypanosoma brucei, Publ: The Journal of Cell Biology, vol./Iss: 137(3), pp. 715-727, Date: May 5, 1997.
50 Author: Magez et al., Title: Specific Uptake Tumor Necrosis Factor—a is Involved in Growth Control of Trypanosoma brucei, Publ: The Journal of Cell Biology, vol./Iss: 137(3), pp. 715-727, Date: May 5, 1997.
51 Author: Marshall, E., Title: Gene Therapy's Growing Pains, Publ: Science, vol./Iss: 269(5227), pp. 1050-1055, Date: Aug. 25, 1995.
52 Author: Maruyama et al., Title: Targeting Efficiency of PEG-Immunoliposome-Conjugated Antibodies at PEG Terminals (Abstract Only-Applicants do not have comple copy), Publ: Advanced Drug Delivery Reviews, vol./Iss: 24, pp. 235-242, Date: Mar. 17, 1997.
53 Author: Mathias et al., Title: Sulfur-Substituted Polyoxyethylenes Sequential Ether-Thioether Copolymers, Publ: Crown Ethers and Phase Transfer Catalysis in Polymer Science, vol./Iss:, pp. 359-370, Date: Jan. 1, 1984.
54 Author: Morris et al., Title: Validation of the Biotinyl Ligant-Avidin-Gold Technique, Publ: Cyctochemistry, vol./Iss: 40, pp. 711-721, Date: Jan. 1, 1992.
55 Author: Mrksich et al., Title: Surface Plasmon Resonance Permits in Situ Measurement of Protein Adsorption on Self-Assembled Monolayers of Alkanethiolates on Gold, Publ: Langmuir, vol./Iss: 11, pp. 4383-4385, Date: Jan. 1, 1995.
56 Author: Nakashima et al., Title: Electrochemical Characterization of an Assembled Monolayers of alpha-Methoxy-omegamercapto-poly(ethylene glycol) on Gold and Complex Formation of the Monolayer with alpha-Cyclodextrin, Publ: Chemistry Letters, vol./Iss:, pp. 731-732, Date: Jan. 1, 1996.
57 Author: Nakashima et al., Title: Electrochemical Characterization of an Assembled Monolayers of α-Methoxy-ωmercapto-poly(ethylene glycol) on Gold and Complex Formation of the Monolayer with α-Cyclodextrin, Publ: Chemistry Letters, vol./Iss:, pp. 731-732, Date: Jan. 1, 1996.
58 Author: Niwa et al., Title: Two-Dimensional Array of Poly(methacrylic acid) Brushes on Gold Substrates. Interaction with Ferrocen-Terminated Poly(oxyethylene)s, Publ: Macromolecules, vol./Iss: 28(23), pp. 7770-7774, Date: Nov. 6, 1995.
59 Author: Ormann et al., Title: Expression of Tumor Necrosis Factor-alpha Receptors on Bovine Macrophages, Lymphocytes and Polymorphonuclear Luekocytes Internalization of Receptor-Bound Ligand, and Some Functional Effects, Publ: Lymphokine Research, vol./Iss: 9(1), pp. 43-58, Date: Jan. 1, 1990.
60 Author: Ormann et al., Title: Expression of Tumor Necrosis Factor-α Receptors on Bovine Macrophages, Lymphocytes and Polymorphonuclear Luekocytes Internalization of Receptor-Bound Ligand, and Some Functional Effects, Publ: Lymphokine Research, vol./Iss: 9(1), pp. 43-58, Date: Jan. 1, 1990.
61 Author: Otsuka et el., Title: Quantitative and Reversible Lectin-Induced Association of Gold Nanoparticles Modified with alpha-Lactosyl-omega-mercapto-poly(ethylene glycol), Publ: Journal of the American Chemical Society, vol./Iss: 123, pp. 8226-8230, Date: Feb. 20, 2001..
62 Author: Otsuka et el., Title: Quantitative and Reversible Lectin-Induced Association of Gold Nanoparticles Modified with α-Lactosyl-ω-mercapto-poly(ethylene glycol), Publ: Journal of the American Chemical Society, vol./Iss: 123, pp. 8226-8230, Date: Feb. 20, 2001..
63 Author: Paciotti et al., Title: (XP-001537146) #3858-Comparison of the Toxicity and Pharmacokinetics of Neat and Colloidal Gold Bound TNF, Publ: Proceedings of the American Association for Cancer Research, vol./Iss: 40, pp. 585, Date: Mar. 1, 1999.
64 Author: Paciotti et al., Title: (XP-001537146) #3858—Comparison of the Toxicity and Pharmacokinetics of Neat and Colloidal Gold Bound TNF, Publ: Proceedings of the American Association for Cancer Research, vol./Iss: 40, pp. 585, Date: Mar. 1, 1999.
65 Author: Paciotti et al., Title: (XP-001537149) #1048-The Use of Colloidal Gold in Cytokine Immunotherapy, Publ: Proceedings of the American Association for Cancer Research, vol./Iss: 39, pp. 153, Date: Mar. 1, 1998.
66 Author: Paciotti et al., Title: (XP-001537149) #1048—The Use of Colloidal Gold in Cytokine Immunotherapy, Publ: Proceedings of the American Association for Cancer Research, vol./Iss: 39, pp. 153, Date: Mar. 1, 1998.
67 Author: Paciotti et al., Title: Interleukin 1 Directly Regulates Hormone-Dependent Human Breast Cancer Cell Proliferation in Vivo, Publ: Molecular Endocrinology, vol./Iss: 2, pp. 459-464, Date: Jan. 1, 1988.
68 Author: Paciotti et al., Title: Interleukin 1alpha Differentially Synchronizes Estrogen Dependent and Estrogen-Independent Human Breast Cells in G0/G1 Phase of the Cell Cycle, Publ: Anti-Cancer Research, vol./Iss: 11, pp. 25-32, Date: Jan. 1, 1991.
69 Author: Paciotti et al., Title: Interleukin 1α Differentially Synchronizes Estrogen Dependent and Estrogen-Independent Human Breast Cells in G0/G1 Phase of the Cell Cycle, Publ: Anti-Cancer Research, vol./Iss: 11, pp. 25-32, Date: Jan. 1, 1991.
70 Author: Paciotti et al., Title: Interleukin 2 Differentially Effects the Proliferation of a Hormone-Dependent and a Hormone-Independent Human Breast Cancer Cell Line in Vitro and in Vivo, Publ: Anti-Cancer Research, vol./Iss: 8, pp. 1233-1249, Date: Jan. 1, 1988.
71 Author: Peters et al., Title: Binding and Internalization of Biotinylated Interleukin-2 in Human Lymphocytes, Publ: Blood, vol./Iss: 76, pp. 97-104, Date: Jan. 1, 1990.
72 Author: Prakken et al., Title: Artificial Antigen-Presenting Cells as a Tool to Exploit the Immune ‘Synapse’, Publ: Nature Medicine, vol./Iss: 6(12), pp. 1406-1410, Date: Dec. 1, 2000.
73 Author: Prakken et al., Title: Artificial Antigen-Presenting Cells as a Tool to Exploit the Immune 'Synapse', Publ: Nature Medicine, vol./Iss: 6(12), pp. 1406-1410, Date: Dec. 1, 2000.
74 Author: Prime et al., Title: Adsorption of Proteins onto Surfaces Containing End-Attached Oligo(ethylene oxide): A Model System Using Self-Assembled Monolayers, Publ: Journal of the American Chemical Society, vol./Iss: 115, pp. 10714-10721, Date: Jan. 1, 1993.
75 Author: Rabolt, J.F., Title: Design and Construction of Two Component Heterogenous Polymer Surfaces by Self Assembly, Publ: Polymer Preprints, vol./Iss: 36(1), pp. 84, Date: Apr. 1, 1995.
76 Author: Roitt et al., Title: The Cytokine Network, Publ: Immunology, vol./Iss: 3rd Ed., pp. 8-15, Date: Jan. 1, 1993.
77 Author: Ross et al., Title: Gene Therapy in the United States: A Five-Year Status Report, Publ: Human Gene Therapy, vol./Iss: 7, pp. 1781-1790, Date: Sep. 10, 1996.
78 Author: Rubanyi, G.M., Title: The Future of Human Gene Therapy, Publ: Molecular Aspects of Medicine, vol./Iss: 22, pp. 113-142, Date: Jan. 1, 2001.
79 Author: Schmitmeier et al., Title: Anti-Invasive Effect of Contortrostatin. A snake Venom Disintegrin, and TNF-alpha on Malignant Glioma Cells-(Applicants do not have complete copy), Publ: Anti-Cancer Research, vol./Iss: 20(6B), pp. 4227-4233, Date: Nov. 1, 2000.
80 Author: Tannock et al., Title:, Publ: The Basic Science of Oncology, vol./Iss: 2nd Ed., pp. 352-353, Date: Jan. 1, 1992.
81 Author: Tomii et al., Title: Production of Anti-Platelet-Activating Factor Antibodies by the Use of Colloidal Gold as Cancer, Publ: Japane Journal of Medicinal Science and Biology, vol./Iss: 44, pp. 75-80, Date: Jan. 1, 1991.
82 Author: USPTO, Title: USPTO Office Action-cited 11/516,175, Publ: USPTO Office Action, vol./Iss:, pp. 1-9, Date: Jun. 5, 2009.
83 Author: USPTO, Title: USPTO Office Action—cited 11/516,175, Publ: USPTO Office Action, vol./Iss:, pp. 1-9, Date: Jun. 5, 2009.
84 Author: USPTO, Title: USPTO Office Action-cited in 11/516,175, Publ: USPTO Office Action, vol./Iss:, pp. 1-10, Date: Sep. 11, 2009.
85 Author: USPTO, Title: USPTO Office Action—cited in 11/516,175, Publ: USPTO Office Action, vol./Iss:, pp. 1-10, Date: Sep. 11, 2009.
86 Author: USPTO, Title: USPTO Office Action-cited in 11/805,383, Publ: USPTO Office Action, vol./Iss:, pp. 1-16, Date: Apr. 17, 2009.
87 Author: USPTO, Title: USPTO Office Action—cited in 11/805,383, Publ: USPTO Office Action, vol./Iss:, pp. 1-16, Date: Apr. 17, 2009.
88 Author: USPTO, Title: USPTO Office Action-cited in 11/805,383, Publ: USPTO Office Action, vol./Iss:, pp. 1-33, Date: Aug. 19, 2009.
89 Author: USPTO, Title: USPTO Office Action—cited in 11/805,383, Publ: USPTO Office Action, vol./Iss:, pp. 1-33, Date: Aug. 19, 2009.
90 Author: Van Den Pol, A. N., Title: Colloidal Gold and Biotin-Avidin Conjugates as Ultrasound Markers for Neural Antigens, Publ: Quarterly Journal of Experimental Physiology, vol./Iss:, pp. 1-33, Date: Jan. 1, 1984.
91 Author: Van Rensen et al., Title: Liposomes with Incorporated MHC Class II/Peptide Complexes as Antigen Presenting Vesicles for Specific T Cell Activation, Publ: Pharmaceutical Research, vol./Iss: 16(2), pp. 198-204, Date: Jan. 1, 1999.
92 Author: Verma et al., Title: Gene Therapy-Promises, Problems and Prospects, Publ: Nature, vol./Iss: 389, pp. 239-242, Date: Sep. 18, 1997.
93 Author: Verma et al., Title: Gene Therapy—Promises, Problems and Prospects, Publ: Nature, vol./Iss: 389, pp. 239-242, Date: Sep. 18, 1997.
94 Author: Vidal et al., Title: Steric Stabilization of Polystyrene Colloids Using Thiol-ended Polyethylene Oxide, Publ: Polymers for Advanced Technologies, vol./Iss: 6, pp. 473-479, Date: Nov. 15, 1994.
95 Author: Walden et al., Title: Induction of Regulatory T-lymphocyte Responses by Liposomes Carrying Major Histocompatibility Complex Molecules and Foreing Antigen, Publ: Nature, vol./Iss: 315, pp. 327-329, Date: May 23, 1985.
96 Author: Wink et al., Title: Interation Between Plasmid DNA and Cationic Polymers Studied by Surface Plasmon Resonance Spectrometry Publ: Analytical Chemistry, vol./Iss: 71, pp. 801-805, Date: Jan. 1, 1999.
97 Author: Wuelling et al., Title: Nanometer Gold Clusters Protected by Surface-Bound Monolayers of Thiolated Poly (ethylene glycol) Polymer Electrolyte, Publ: Journal of the American Chemical Society, vol./Iss: 120, pp. 12696-12697, Date: Jan. 1, 1998.
98 Author:, Title: "Cancer", Publ: Taber's Cyclopedic Medical Disctionary, vol./Iss: Ed. 16, pp. 274, Date: Jan. 1, 1985.
99 Author:, Title: Appicants do not have translation; Concise Statement: This reference describes the use of acetal-PEG-dimethyllaminotheylpolymethacrylate as a dispersion stabilizer for fine particles of gold, Publ: Polymer Preprints, vol./Iss: 49(3), pp. 650, Date: Jan. 1, 2000.
100 Author:, Title: Australian Office Action-Application No. 2002259107, Publ: Australian Office Action, vol./Iss:, pp. 1-2, Date: Nov. 14, 2005.
101 Author:, Title: Australian Office Action—Application No. 2002259107, Publ: Australian Office Action, vol./Iss:, pp. 1-2, Date: Nov. 14, 2005.
102 Author:, Title: Canadian Office Action-2,309,604, Publ: Canadian Office Action, vol./Iss:, pp. 1-4, Date: Feb. 11, 2006.
103 Author:, Title: Canadian Office Action—2,309,604, Publ: Canadian Office Action, vol./Iss:, pp. 1-4, Date: Feb. 11, 2006.
104 Author:, Title: Canadian Office Action-2,309,604, Publ: Canadian Office Action, vol./Iss:, pp. 1-4, Date: May 18, 2006.
105 Author:, Title: Canadian Office Action—2,309,604, Publ: Canadian Office Action, vol./Iss:, pp. 1-4, Date: May 18, 2006.
106 Author:, Title: Canadian Office Action-Application No. 2,448,607, Publ: Canadian Office Action, vol./Iss:, pp. 1-4, Date: Apr. 7, 2009.
107 Author:, Title: Canadian Office Action—Application No. 2,448,607, Publ: Canadian Office Action, vol./Iss:, pp. 1-4, Date: Apr. 7, 2009.
108 Author:, Title: EPO Office Action cited in 02729092.3 (CYT0091EP), Publ: EPO Office Action, vol./Iss:, pp. 1-4, Date: Oct. 23, 2009.
109 Author:, Title: EPO Search Report cited in EP Application No. 05722719.9 (CYT-0094EP) Publ: EPO Search Report, vol./Iss:, pp. 1-4, Date: Sep. 15, 2010.
110 Author:, Title: EPO Search Report-98957757.2, Publ: EPO Search Report, vol./Iss:, pp. 1-3, Date: Oct. 31, 2003.
111 Author:, Title: EPO Search Report—98957757.2, Publ: EPO Search Report, vol./Iss:, pp. 1-3, Date: Oct. 31, 2003.
112 Author:, Title: EPO Search Report-98957757.2, Publ: EPO Search Report, vol./Iss:, pp. 1-4, Date: Oct. 31, 2003.
113 Author:, Title: EPO Search Report—98957757.2, Publ: EPO Search Report, vol./Iss:, pp. 1-4, Date: Oct. 31, 2003.
114 Author:, Title: Japanese Office Action cited in 2000-520162 (with English translation), Publ: Japanese Office Action, vol./Iss:, pp. 1-3, Date: Jun. 4, 2010.
115 Author:, Title: Japanese Office Action cited in 2000-520162 (with English translation), Publ: Japanese Office Action, vol./Iss:, pp. 1-3, Date: Oct. 22, 2009.
116 Author:, Title: Japanese Office Action cited in 2000-520162 (with English translation), Publ: Japanese Office Action, vol./Iss:, pp. 1-7, Date: Apr. 14, 2009.
117 Author:, Title: Japanese Office Action cited in 2002-584861 (with English translation), Publ: Japanese Office Action, vol./Iss:, pp. 1-10, Date: Dec. 25, 2008.
118 Author:, Title: Japanese Office Action cited in 2006-551620 (with English translation), Publ: Japanese Office Action, vol./Iss:, pp. 1-4, Date: Jul. 13, 2010.
119 Author:, Title: Office Action-Peoples Republic of China-Application No. 200580009719.0 (with English translation) Publ: Peoples Republic of China-Office Action, vol./Iss:, pp. 1-15, Date: Mar. 20, 2009.
120 Author:, Title: Office Action—Peoples Republic of China—Application No. 200580009719.0 (with English translation) Publ: Peoples Republic of China—Office Action, vol./Iss:, pp. 1-15, Date: Mar. 20, 2009.
121 Author:, Title: PCT International Search Report and Written Opinion issued in PCT/US08/77239 (CYT-0166) Publ: PCT International Search Report, vol./Iss:, pp. 107, Date: Dec. 5, 2008.
122 Author:, Title: USPTO Office Action-cited in 09/189,657, Publ: USPTO Office Action, vol./Iss:, pp. 1-15, Date: Apr. 11, 2008.
123 Author:, Title: USPTO Office Action—cited in 09/189,657, Publ: USPTO Office Action, vol./Iss:, pp. 1-15, Date: Apr. 11, 2008.
124 Author:, Title: USPTO Office Action-cited in 10/672,144 (CYT-0027), Publ: USPTO Office Action, vol./Iss:, pp. 1-5, Date: Nov. 15, 2010.
125 Author:, Title: USPTO Office Action—cited in 10/672,144 (CYT-0027), Publ: USPTO Office Action, vol./Iss:, pp. 1-5, Date: Nov. 15, 2010.
126 Author:, Title: USPTO Office Action-cited in 10/672,144, Publ: USPTO Office Action, vol./Iss:, pp. 1-10, Date: Apr. 15, 2009.
127 Author:, Title: USPTO Office Action—cited in 10/672,144, Publ: USPTO Office Action, vol./Iss:, pp. 1-10, Date: Apr. 15, 2009.
128 Author:, Title: USPTO Office Action-cited in 10/672,144, Publ: USPTO Office Action, vol./Iss:, pp. 1-6, Date: Aug. 5, 2010.
129 Author:, Title: USPTO Office Action—cited in 10/672,144, Publ: USPTO Office Action, vol./Iss:, pp. 1-6, Date: Aug. 5, 2010.
130 Author:, Title: USPTO Office Action-cited in 10/672,144, Publ: USPTO Office Action, vol./Iss:, pp. 1-8, Date: Jan. 20, 2010.
131 Author:, Title: USPTO Office Action—cited in 10/672,144, Publ: USPTO Office Action, vol./Iss:, pp. 1-8, Date: Jan. 20, 2010.
132 Author:, Title: USPTO Office Action-cited in 10/672,144, Publ: USPTO Office Action, vol./Iss:, pp. 1-8, Date: Oct. 17, 2007.
133 Author:, Title: USPTO Office Action—cited in 10/672,144, Publ: USPTO Office Action, vol./Iss:, pp. 1-8, Date: Oct. 17, 2007.
134 Author:, Title: USPTO Office Action—cited in 11/016,204, Publ: USPTO Office Action, vol./Iss:, pp. 1-36, Date: Jul. 7, 2009.
135 Author:, Title: USPTO Office Action-cited in 12/250,126, Publ: USPTO Office Action, vol./Iss:, pp. 1-12, Date: Jun. 7, 2010.
136 Author:, Title: USPTO Office Action—cited in 12/250,126, Publ: USPTO Office Action, vol./Iss:, pp. 1-12, Date: Jun. 7, 2010.
137 Author:, Title: USPTO Office Action—cited in 12/708,326 (CYT-0110), Publ: USPTO Office Action, vol./Iss:, pp. 1-15, Date: Nov. 8, 2010.
138 Office Action in U.S. Appl. No. 11/046,204, filed Oct. 16, 2008.
US20140220133 * Nov 27, 2013 Aug 7, 2014 Cytimmune Sciences, Inc. Nanotechnology Based Medicine for Biodefense
U.S. Classification 436/525, 436/518
International Classification G01N33/553, C07K14/525, C07K16/24, A61K47/48, A61K9/00, A61K39/39
Cooperative Classification A61K47/6923, A61K47/60, A61K38/191, A61K49/0056, A61K39/39, C07K14/525, A61K2039/55516, A61K38/39, A61K2039/55522, C07K16/241, A61K2039/55505, A61K49/0013, A61K49/0065, A61K49/0017, A61K51/1244
European Classification C07K14/525, A61K49/00P4, C07K16/24B, A61K49/00P4F8R, A61K39/39, A61K49/00P12, A61K38/39, A61K51/12H, A61K38/19A, A61K49/00P4F, A61K47/48K6P, A61K47/48W8B